Regeneron’s Antibody Drug Cut Risk of Covid-19 by 82%, Company Says - The Wall Street Journal
- Regeneron’s Antibody Drug Cut Risk of Covid-19 by 82%, Company Says The Wall Street Journal
- Regeneron's antibody drug shows protection against COVID-19 for up to 8 months Yahoo! Voices
- Regeneron reports COVID-19 antibody cocktail reduced infection risk by 82% for 8 months — so far Fox News
- Regeneron's Antibody Drug Helps Prevent COVID-19 For Up To 8 Months, Company Trial Results Show CBS Miami
- Regeneron says antibody cocktail cuts COVID-19 risk for up to eight months | TheHill The Hill
source https://news.google.com/__i/rss/rd/articles/CBMiaWh0dHBzOi8vd3d3Lndzai5jb20vYXJ0aWNsZXMvcmVnZW5lcm9ucy1hbnRpYm9keS1kcnVnLWN1dC1yaXNrLW9mLWNvdmlkLTE5LWJ5LTgyLWNvbXBhbnktc2F5cy0xMTYzNjM4NTQ1OdIBAA?oc=5
Comments
Post a Comment